{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:20:33Z","timestamp":1786612833366,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030924","name":"Kaiser Permanente Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.amjmed.2023.10.031","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T04:52:30Z","timestamp":1700715150000},"page":"258-265.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System \u2014 California, 2008-2019"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0567-8294","authenticated-orcid":false,"given":"Debbie E.","family":"Malden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit S.","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Y.","family":"Tartof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2023.10.031_bib0001","unstructured":"United States Centers for Disease Control and Prevention. Tuberculosis (TB): Data and statistics. Available at: https:\/\/www.cdc.gov\/tb\/statistics\/default.htm. Accessed January 15, 2023."},{"key":"10.1016\/j.amjmed.2023.10.031_bib0002","unstructured":"World Health Organization. Global tuberculosis report 2019. Available at:https:\/\/www.who.int\/publications\/i\/item\/9789241565714. Accessed January 15, 2023."},{"key":"10.1016\/j.amjmed.2023.10.031_bib0003","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240027077. Accessed January 15, 2023."},{"issue":"12","key":"10.1016\/j.amjmed.2023.10.031_bib0004","doi-asserted-by":"crossref","first-page":"441","DOI":"10.15585\/mmwr.mm7112a1","article-title":"Tuberculosis - United States, 2021","volume":"71","author":"Filardo","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.amjmed.2023.10.031_bib0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jhep.2020.09.013","article-title":"A global investment framework for the elimination of hepatitis B","volume":"74","author":"Howell","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.amjmed.2023.10.031_bib0006","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Preventive Services Task Force","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.amjmed.2023.10.031_bib0007","doi-asserted-by":"crossref","first-page":"e3468","DOI":"10.1093\/cid\/ciaa1662","article-title":"Tuberculosis Epidemiologic Studies Consortium. Prevalence of latent tuberculosis infection among non-US-born persons by country of birth-united states, 2012-2017","volume":"73","author":"Collins","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2023.10.031_bib0008","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amjmed.2023.10.031_bib0009","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s10620-021-07056-5","article-title":"Prevalence of latent tuberculosis infection among persons with chronic hepatitis B virus infection: a systematic review and meta-analysis","volume":"67","author":"Chen","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.amjmed.2023.10.031_bib0010","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10903-021-01231-6","article-title":"Epidemiology and prevention of tuberculosis and chronic hepatitis B virus infection in the United States","volume":"23","author":"Chitnis","year":"2021","journal-title":"J Immigr Minor Health"},{"issue":"1","key":"10.1016\/j.amjmed.2023.10.031_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Contributors. Screening and testing for hepatitis B virus infection: CDC recommendations - United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.amjmed.2023.10.031_bib0012","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/hep.26286","article-title":"Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010","volume":"58","author":"Hu","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.amjmed.2023.10.031_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273363","article-title":"Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems","volume":"17","author":"Fischer","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.amjmed.2023.10.031_bib0014","doi-asserted-by":"crossref","first-page":"A330","DOI":"10.1016\/j.chest.2020.08.327","article-title":"Prevalence of latent TB among US adults with chronic hepatitis B virus: a retrospective study of the national health and nutrition examination survey","volume":"158","author":"Hubbard","year":"2020","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.amjmed.2023.10.031_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/PHH.0000000000001536","article-title":"Prevalence of hepatitis B virus and latent tuberculosis coinfection in the United States","volume":"28","author":"Wong","year":"2022","journal-title":"J Public Health Manag Pract"},{"key":"10.1016\/j.amjmed.2023.10.031_bib0016","doi-asserted-by":"crossref","first-page":"A159","DOI":"10.1136\/thoraxjnl-2014-206260.318","article-title":"P189\u2005Should screening for chronic viral hepatitis in patients with tuberculosis be introduced to NICE guidelines?","volume":"69","author":"Potter","year":"2014","journal-title":"Thorax"},{"issue":"29","key":"10.1016\/j.amjmed.2023.10.031_bib0017","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.3748\/wjg.v21.i29.8920","article-title":"Viral hepatitis prevalence in patients with active and latent tuberculosis","volume":"21","author":"Nooredinvand","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjmed.2023.10.031_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249012","article-title":"State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity","volume":"16","author":"Mirzazadeh","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.amjmed.2023.10.031_bib0019","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30831","article-title":"Chronic hepatitis B prevalence among foreign-born and US-born adults in the United States, 1999-2016","volume":"71","author":"Le","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.amjmed.2023.10.031_bib0020","first-page":"602","article-title":"Screening for hepatitis B virus infection among refugees diagnosed with latent tuberculosis in an Italian community","volume":"33","author":"Tocco-Tussardi","year":"2021","journal-title":"Ann Ig"},{"issue":"13","key":"10.1016\/j.amjmed.2023.10.031_bib0021","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal hepatitis B vaccination in adults aged 19-59 years: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.amjmed.2023.10.031_bib0022","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.amjmed.2023.10.031_bib0023","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jama.2023.4899","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement","volume":"329","author":"Mangione","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2023.10.031_bib0024","unstructured":"World Health Organization. The end TB strategy. Available at:https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/the-end-tb-strategy. Accessed January 15, 2023."},{"issue":"9","key":"10.1016\/j.amjmed.2023.10.031_bib0025","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2105\/AJPH.2015.302662","article-title":"Tuberculosis Epidemiologic Studies Consortium. Preventing infectious pulmonary tuberculosis among foreign-born residents of the United States","volume":"105","author":"Davidow","year":"2015","journal-title":"Am J Public Health"},{"issue":"11","key":"10.1016\/j.amjmed.2023.10.031_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27577","article-title":"Association of number of doses with hepatitis B vaccine series completion in US adults","volume":"3","author":"Bruxvoort","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323007076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323007076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:31:01Z","timestamp":1762079461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934323007076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0002934323007076"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.10.031","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System \u2014 California, 2008-2019","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}